Nexpoint Asset Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Nexpoint Asset Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-110,912	Closed	-$6.66M	–	246
2021 Q1	$6.66M	Buy	+110,912	New	+$4.02M	1.74%	19

Nexpoint Asset Management's PAND Position: Q2 2021 in Review

Nexpoint Asset Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 110,912 shares — an estimated $6.66M sold.

Nexpoint Asset Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $6.66M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Nexpoint Asset Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Nexpoint Asset Management sold 110,912 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $6.66M.
Nexpoint Asset Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Nexpoint Asset Management's Pandion Therapeutics Inc. Common Stock position peaked at $6.66M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Nexpoint Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.